Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston
3
×
boston blog main
boston top stories
clinical trials
eventide asset management
3
×
life sciences
national blog main
fda
national top stories
new york blog main
san francisco blog main
software
aligos therapeutics
ally bridge group
arrowmark partners
baker brothers life sciences
benzodiazepine
beta bionics
big data analytics
bigfoot biomedical
biotech ipos
blackrock
blackstone group
blepharitis
boston university
casdin capital
cavion
cephalgia
chronic hepatitis b virus
congenital hyperinsulinism
david goldstein
deals
demodex blepharitis
depression
dexcom
diabetes
diabetic nephropathy
drug delivery
edward damiano
What
medicines
million
analysis
beta
bio
bionics
biotech
biotechs
blood
bring
central
closed
cns
company
develop
developing
device
diabetes
diseases
disorder
driven
drug
drugs
emerged
employing
genetic
goldfinch
heads
ipo
ipos
kept
key
kidney
later
lead
leads
levels
manages
medical
monitors
Language
unset
Current search:
boston
×
biotech
×
" eventide asset management "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests